A news story about Health Canada's investment in a new post-market drug surveillance network that was published online at www.cmaj.ca on July 16, 2008, and in the August 26 print issue should have stated that rofecoxib (Vioxx) was withdrawn from the Canadian market in 2004.1
REFERENCE
- 1.Silversides, A. Health Canada's investment in new post-market drug surveillance network a “pittance.” CMAJ 2008;179:412-3. [DOI] [PMC free article] [PubMed]